1. Home
  2. CELZ vs TTNP Comparison

CELZ vs TTNP Comparison

Compare CELZ & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELZ
  • TTNP
  • Stock Information
  • Founded
  • CELZ 1998
  • TTNP 1991
  • Country
  • CELZ United States
  • TTNP United States
  • Employees
  • CELZ N/A
  • TTNP 4
  • Industry
  • CELZ Biotechnology: Pharmaceutical Preparations
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CELZ Health Care
  • TTNP Health Care
  • Exchange
  • CELZ Nasdaq
  • TTNP Nasdaq
  • Market Cap
  • CELZ 5.5M
  • TTNP 5.9M
  • IPO Year
  • CELZ N/A
  • TTNP 1996
  • Fundamental
  • Price
  • CELZ $2.68
  • TTNP $4.40
  • Analyst Decision
  • CELZ
  • TTNP
  • Analyst Count
  • CELZ 0
  • TTNP 0
  • Target Price
  • CELZ N/A
  • TTNP N/A
  • AVG Volume (30 Days)
  • CELZ 84.5K
  • TTNP 44.6K
  • Earning Date
  • CELZ 08-08-2025
  • TTNP 08-14-2025
  • Dividend Yield
  • CELZ N/A
  • TTNP N/A
  • EPS Growth
  • CELZ N/A
  • TTNP N/A
  • EPS
  • CELZ N/A
  • TTNP N/A
  • Revenue
  • CELZ $14,000.00
  • TTNP N/A
  • Revenue This Year
  • CELZ N/A
  • TTNP N/A
  • Revenue Next Year
  • CELZ N/A
  • TTNP N/A
  • P/E Ratio
  • CELZ N/A
  • TTNP N/A
  • Revenue Growth
  • CELZ 55.56
  • TTNP N/A
  • 52 Week Low
  • CELZ $1.69
  • TTNP $3.03
  • 52 Week High
  • CELZ $6.90
  • TTNP $14.80
  • Technical
  • Relative Strength Index (RSI)
  • CELZ 71.60
  • TTNP 48.35
  • Support Level
  • CELZ $2.36
  • TTNP $4.23
  • Resistance Level
  • CELZ $2.89
  • TTNP $4.65
  • Average True Range (ATR)
  • CELZ 0.24
  • TTNP 0.27
  • MACD
  • CELZ 0.05
  • TTNP -0.03
  • Stochastic Oscillator
  • CELZ 87.80
  • TTNP 30.67

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Share on Social Networks: